{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:13:33Z","timestamp":1790345613935,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/P027989\/1"],"award-info":[{"award-number":["MR\/P027989\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006182","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Esp\u00edrito Santo","doi-asserted-by":"publisher","award":["70984379\/2015"],"award-info":[{"award-number":["70984379\/2015"]}],"id":[{"id":"10.13039\/501100006182","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ebiom.2022.104378","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T06:24:24Z","timestamp":1669789464000},"page":"104378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["3\u2032Nucleotidase\/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine"],"prefix":"10.1016","volume":"86","author":[{"given":"Juliana B.T.","family":"Carnielli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Forrester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro R.","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Monti-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos H.N.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynaldo","family":"Dietze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy C.","family":"Mottram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2022.104378_bib1","series-title":"Leishmaniasis","author":"World Health Organization","year":"2020"},{"issue":"7619","key":"10.1016\/j.ebiom.2022.104378_bib2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.ebiom.2022.104378_bib3","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7717","key":"10.1016\/j.ebiom.2022.104378_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41586-018-0356-z","article-title":"Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis","volume":"560","author":"Wyllie","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104378_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1021\/acsinfecdis.8b00298","article-title":"Drug discovery for kinetoplastid diseases: future directions","volume":"5","author":"Rao","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104378_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0277-5379(88)90336-7","article-title":"Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)","volume":"24","author":"Hilgard","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104378_bib7","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.ebiom.2022.104378_bib8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104378_bib9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4269\/ajtmh.2011.10-0661","article-title":"Phase IV trial of miltefosine in adults and children for treatment of visceral leishmaniasis (kala-azar) in Bangladesh","volume":"85","author":"Rahman","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"33","key":"10.1016\/j.ebiom.2022.104378_bib12","doi-asserted-by":"crossref","first-page":"23766","DOI":"10.1074\/jbc.M605214200","article-title":"Phospholipid translocation and miltefosine potency require both L. donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","volume":"281","author":"Perez-Victoria","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"50","key":"10.1016\/j.ebiom.2022.104378_bib13","first-page":"49965","article-title":"Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from Leishmania involved in drug resistance","volume":"278","author":"Perez-Victoria","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104378_bib14","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug","volume":"47","author":"Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine)","volume":"22","author":"Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib16","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1038\/s41467-019-13344-6","article-title":"Coupling chemical mutagenesis to next generation sequencing for the identification of drug resistance mutations in Leishmania","volume":"10","author":"Bhattacharya","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104378_bib17","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.45.9.2468-2474.2001","article-title":"Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator","volume":"45","author":"Perez-Victoria","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104378_bib18","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1128\/AAC.00423-06","article-title":"Combination of suboptimal doses of inhibitors targeting different domains of LtrMDR1 efficiently overcomes resistance of Leishmania spp. to Miltefosine by inhibiting drug efflux","volume":"50","author":"Perez-Victoria","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib19","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3201\/eid1804.110841","article-title":"Leishmania resistance to miltefosine associated with genetic marker","volume":"18","author":"Cojean","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasites Vectors"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154101","article-title":"Genomic and molecular characterization of miltefosine resistance in Leishmania infantum strains with either natural or acquired resistance through experimental selection of intracellular amastigotes","volume":"11","author":"Mondelaers","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2022.104378_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijpddr.2019.02.005","article-title":"Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake","volume":"11","author":"Espada","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104378_bib23","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1128\/AAC.49.7.2677-2686.2005","article-title":"Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions","volume":"49","author":"Rakotomanga","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib24","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1128\/AAC.01123-06","article-title":"Miltefosine affects lipid metabolism in Leishmania donovani promastigotes","volume":"51","author":"Rakotomanga","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib25","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00436-014-3755-6","article-title":"Comparative transcript expression analysis of miltefosine-sensitive and miltefosine-resistant Leishmania donovani","volume":"113","author":"Kulshrestha","year":"2014","journal-title":"Parasitol Res"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104378_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00666-18","article-title":"Lipase precursor-like protein promotes miltefosine tolerance in Leishmania donovani by enhancing parasite infectivity and eliciting anti-inflammatory responses in host macrophages","volume":"62","author":"Deep","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","article-title":"A\u00a0proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death","volume":"6","author":"Vergnes","year":"2007","journal-title":"Mol Cell Proteomics"},{"issue":"19","key":"10.1016\/j.ebiom.2022.104378_bib28","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1111\/febs.12449","article-title":"Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species","volume":"280","author":"Das","year":"2013","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104378_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","article-title":"Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death","volume":"135","author":"Mishra","year":"2013","journal-title":"Exp Parasitol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104378_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005641","article-title":"Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress","volume":"11","author":"Deep","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104378_bib31","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1111\/febs.14923","article-title":"Iron superoxide dismutase contributes to miltefosine resistance in Leishmania donovani","volume":"286","author":"Veronica","year":"2019","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4269\/ajtmh.18-0949","article-title":"Natural resistance of Leishmania infantum to miltefosine contributes to the low efficacy in the treatment of visceral leishmaniasis in Brazil","volume":"101","author":"Carnielli","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2022.104378_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2018.09.029","article-title":"A\u00a0Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis","volume":"36","author":"Carnielli","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104378_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9061228","article-title":"In\u00a0Vitro susceptibility to miltefosine of Leishmania infantum (syn. L. Chagasi) isolates from different geographical areas in Brazil","volume":"9","author":"Espada","year":"2021","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/S0074-02762012000100006","article-title":"Genetic diversity of Leishmania infantum field populations from Brazil","volume":"107","author":"Segatto","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104378_bib36","article-title":"A\u00a0CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids","volume":"4","author":"Beneke","year":"2017","journal-title":"R\u00a0Soc Open Sci"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104378_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0166-6851(00)00195-X","article-title":"Targeted integration into a rRNA locus results in uniform and high level expression of transgenes in Leishmania amastigotes","volume":"107","author":"Misslitz","year":"2000","journal-title":"Mol Biochem Parasitol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104378_bib38","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nmeth.2551","article-title":"LipidBlast in silico tandem mass spectrometry database for lipid identification","volume":"10","author":"Kind","year":"2013","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib39","first-page":"115","article-title":"Technical Advance: a novel technique for the sensitive quantification of acyl CoA esters from plant tissues","volume":"25","author":"Larson","year":"2001","journal-title":"Plant J"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104378_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","article-title":"High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells","volume":"31","author":"Fu","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104378_bib41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.2673","article-title":"High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity","volume":"31","author":"Pattanayak","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01541-19","article-title":"Causes and effects of loss of classical nonhomologous end joining pathway in parasitic eukaryotes","volume":"10","author":"Nenarokova","year":"2019","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104378_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006117","article-title":"Chromosomal translocations in the parasite Leishmania by a MRE11\/RAD50-independent microhomology-mediated end joining mechanism","volume":"12","author":"Laffitte","year":"2016","journal-title":"PLoS Genet"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00408-19","article-title":"Single-strand annealing plays a major role in double-strand DNA break repair following CRISPR-cas9 cleavage in Leishmania","volume":"4","author":"Zhang","year":"2019","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib45","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104378_bib46","doi-asserted-by":"crossref","first-page":"e00611","DOI":"10.1128\/mBio.00611-13","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain","volume":"4","author":"Rai","year":"2013","journal-title":"mBio"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib47","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4269\/ajtmh.13-0096","article-title":"In\u00a0vitro susceptibility of Leishmania donovani to miltefosine in Indian visceral leishmaniasis","volume":"89","author":"Prajapati","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104378_bib48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jac\/dky450","article-title":"Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain","volume":"74","author":"Eberhardt","year":"2019","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ebiom.2022.104378_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpddr.2020.04.004","article-title":"Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection","volume":"13","author":"Van Bockstal","year":"2020","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104378_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0166-6851(95)00035-Y","article-title":"Isolation and characterization of the gene encoding the surface membrane 3'-nucleotidase\/nuclease of Leishmania donovani","volume":"71","author":"Debrabant","year":"1995","journal-title":"Mol Biochem Parasitol"},{"issue":"21","key":"10.1016\/j.ebiom.2022.104378_bib51","doi-asserted-by":"crossref","first-page":"16366","DOI":"10.1074\/jbc.M908725199","article-title":"Dissection of the functional domains of the Leishmania surface membrane 3'-nucleotidase\/nuclease, a unique member of the class I nuclease family","volume":"275","author":"Debrabant","year":"2000","journal-title":"J\u00a0Biol Chem"},{"issue":"48","key":"10.1016\/j.ebiom.2022.104378_bib52","doi-asserted-by":"crossref","first-page":"37789","DOI":"10.1074\/jbc.M002149200","article-title":"The immunologically protective P-4 antigen of Leishmania amastigotes. A developmentally regulated single strand-specific nuclease associated with the endoplasmic reticulum","volume":"275","author":"Kar","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.ebiom.2022.104378_bib53","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-0-387-77570-8_12","article-title":"Purine and pyrimidine metabolism in Leishmania","volume":"625","author":"Carter","year":"2008","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0166-6851(83)90013-0","article-title":"Evidence for distinct 5'- and 3'-nucleotidase activities in the surface membrane fraction of Leishmania donovani promastigotes","volume":"7","author":"Gottlieb","year":"1983","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ebiom.2022.104378_bib55","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-94-007-7305-9_10","article-title":"Ecto-nucleotidases and ecto-phosphatases from Leishmania and trypanosoma parasites","volume":"74","author":"Freitas-Mesquita","year":"2014","journal-title":"Subcell Biochem"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104378_bib56","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1128\/IAI.01232-13","article-title":"3'-nucleotidase\/nuclease activity allows Leishmania parasites to escape killing by neutrophil extracellular traps","volume":"82","author":"Guimaraes-Costa","year":"2014","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.exppara.2010.11.003","article-title":"Leishmania chagasi: an ecto-3'-nucleotidase activity modulated by inorganic phosphate and its possible involvement in parasite-macrophage interaction","volume":"127","author":"Vieira","year":"2011","journal-title":"Exp Parasitol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib58","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.exppara.2011.07.014","article-title":"Leishmania amazonensis: characterization of an ecto-3'-nucleotidase activity and its possible role in virulence","volume":"129","author":"Paletta-Silva","year":"2011","journal-title":"Exp Parasitol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib59","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1128\/AAC.48.3.852-859.2004","article-title":"Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes","volume":"48","author":"Paris","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104378_bib60","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1128\/AAC.48.8.3010-3015.2004","article-title":"Possible mechanism of miltefosine-mediated death of Leishmania donovani","volume":"48","author":"Verma","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104378_bib61","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02095-17","article-title":"Complex interplay between sphingolipid and sterol metabolism revealed by perturbations to the Leishmania metabolome caused by miltefosine","volume":"62","author":"Armitage","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104378_bib62","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jac\/dkp321","article-title":"Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes","volume":"64","author":"Saint-Pierre-Chazalet","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104378_bib63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbamem.2004.01.010","article-title":"Hexadecylphosphocholine interaction with lipid monolayers","volume":"1661","author":"Rakotomanga","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104378_bib64","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.bbamem.2017.06.008","article-title":"Crossregulation between the insertion of Hexadecylphosphocholine (miltefosine) into lipid membranes and their rheology and lateral structure","volume":"1859","author":"Zulueta Diaz","year":"2017","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104378_bib65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104378_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02507-18","article-title":"Systematic review of host-mediated activity of miltefosine in leishmaniasis through\u00a0immunomodulation","volume":"63","author":"Palic","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422005606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422005606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:46Z","timestamp":1762456846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422005606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":66,"alternative-id":["S2352396422005606"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104378","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3\u2032Nucleotidase\/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104378"}}